Overview

The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male Subjects

Status:
Completed
Trial end date:
2020-10-06
Target enrollment:
Participant gender:
Summary
To evaluate pharmacokinetic/pharmacodynamic characteristics and safety of QDX after single oral administration in healthy Korean male subjects
Phase:
Phase 1
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
Treatments:
Topiramate